Diuretics in the treatment of heart failure: mainstay of therapy or potential hazard?

[1]  M. Domanski,et al.  Diuretic use, progressive heart failure, and death in patients in the DIG study. , 2006, Journal of cardiac failure.

[2]  J. Moran,et al.  Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis , 2006, The Lancet.

[3]  V. Mitrović,et al.  Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: a double-blind, placebo-controlled, ascending-dose trial. , 2005, American heart journal.

[4]  M. Gheorghiade,et al.  Vasopressin antagonism in heart failure. , 2005, Journal of the American College of Cardiology.

[5]  S. Iyengar,et al.  Nesiritide for the treatment of congestive heart failure , 2004, Expert opinion on pharmacotherapy.

[6]  C. Graham.  Pharmacological therapy of acute cardiogenic pulmonary oedema in the emergency department. , 2004, Emergency medicine Australasia : EMA.

[7]  N. Freemantle,et al.  The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. , 2003, European heart journal.

[8]  S. Rajagopalan,et al.  Aldosterone as a target in congestive heart failure. , 2003, The Medical clinics of North America.

[9]  N. Freemantle,et al.  The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment , 2003 .

[10]  W. Welch.  Adenosine type 1 receptor antagonists in fluid retaining disorders , 2002, Expert opinion on investigational drugs.

[11]  P. Poole‐Wilson,et al.  Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. , 2002, International journal of cardiology.

[12]  M. Domanski,et al.  Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. , 1999, Circulation.

[13]  B. Silke.  Diuretic induced changes in symptoms and quality of life. , 1994, British heart journal.

[14]  W. Zoghbi,et al.  Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy. , 1994, The American journal of cardiology.

[15]  S. Yusuf,et al.  Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). , 1990, Circulation.

[16]  M. Hetzel,et al.  Acute and chronic effects of a diuretic monotherapy with piretanide in congestive heart failure—A placebo-controlled trial , 1990, Cardiovascular Drugs and Therapy.

[17]  N. Sharpe,et al.  TREATMENT OF PATIENTS WITH SYMPTOMLESS LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION , 1988, The Lancet.

[18]  G. Sutton,et al.  DOUBLE-BLIND COMPARISON OF CAPTOPRIL ALONE AGAINST FRUSEMIDE PLUS AMILORIDE IN MILD HEART FAILURE , 1987, The Lancet.

[19]  E. Espiner,et al.  Haemodynamic and hormone responses to acute and chronic frusemide therapy in congestive heart failure. , 1980, Clinical science.

[20]  Miles Be,et al.  Letter: Serum-phenytoin. , 1976 .

[21]  J. Nabarro,et al.  Clinical experience with chlorothiazide. , 1958, Lancet.

[22]  M. Schwaiger,et al.  Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure. , 1990, Journal of the American College of Cardiology.